Precision BioSciences, Inc. Common Stock

DTILNASDAQUSD
6.08 USD
0.26 (4.47%)🟢LIVE (AS OF 02:47 PM EDT)
🟢Market: OPEN
Open?$5.83
High?$6.20
Low?$5.83
Prev. Close?$5.82
Volume?128.8K
Avg. Volume?317.3K
VWAP?$6.04
Rel. Volume?0.41x
Bid / Ask
Bid?$6.09 × 100
Ask?$6.13 × 100
Spread?$0.04
Midpoint?$6.11
Valuation & Ratios
Market Cap?143.9M
Shares Out?25.8M
Float?24.3M
Float %?94.0%
P/E Ratio?N/A
P/B Ratio?1.56
EPS?-$1.85
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.32Strong
Quick Ratio?13.32Strong
Cash Ratio?12.43Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
1.56CHEAP
P/S?
4.20FAIR
P/FCF?
N/A
EV/EBITDA?
-1.1CHEAP
EV/Sales?
1.62CHEAP
Returns & Efficiency
ROE?
-49.6%WEAK
ROA?
-29.6%WEAK
Cash Flow & Enterprise
FCF?$-65928000
Enterprise Value?$55.5M
Related Companies
Loading...
News
Profile
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Employees
68
Market Cap
143.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-03-28
Address
302 EAST PETTIGREW STREET
DURHAM, NC 27701
Phone: 919-314-5512